Investors, Pharmaceutical Company Seek Approval Of Securities Claims Settlement
CAMDEN, N.J. — A pharmaceutical company and certain of its executives have agreed to settle for $97 million a securities class action by investors accusing the company of artificially inflating stock...To view the full article, register now.
Already a subscriber? Click here to view full article